Lobbying client · LD-2 disclosures
Ascendis Pharma, Inc.
California
48 filings from 2 registrants · 2020–2026 · latest filed Jul 20, 2026
Reported on its behalf
$4.9M
every LD-2 on file
Its own filed spend
$3.4M
lobbying for itself
Fees to outside firms
$1.5M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Pharmacy
PHA
34 filings
$2.8M on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Who did the lobbying
Every lobbyist named on this client's filings.
- William Burke Rubicon Advisors, LLC27 filingsthrough 2026
- Cary T Gibson Ascendis Pharma, Inc.Covered position: Legis. Staff (Rep. S. Berkley; Rep. R. Gephardt; Rep. R. Carnahan)10 filingsthrough 2024
- Kathy Kulkarni Rubicon Advisors, LLC8 filingsthrough 2021
- Kathy Kulkarni Ascendis Pharma, Inc.Covered position: Health Policy Aide/Legislative Director - Office of Congressman Frank Pallone Jr.1 filingthrough 2024
2 of 4 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
The 20 most recent of 48 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: ascendis-pharma-inc.